COVID-19 has drastically changed the role of diagnostics in the global healthcare system. We have seen great innovations that have helped medical professionals identify the disease and, detect and track emerging mutations of importance.

NovaTalk discusses the role of diagnostics tests and sequencing in managing a global pandemic with a panel of medical experts- Professor Chris Molloy (the founding CEO of the Medicines Discovery Catapult), Professor Sharon Peacock (the Executive Director and Chair of the COVID-19 Genomics UK (COG-UK) consortium), Dr. Matthew Dryden (the founding member of ISAC Academy) and Professor Steven Jones (world renowned immunologist & microbiologist).